Nieva Harry Reyes, Kashyap Aparajita, Voss Erica A, Ostropolets Anna, Anand Adit, Ketenci Mert, Defalco Frank J, Choi Young Sang, Li Yanwei, Allen Monica N, Guang Stephanie A, Natarajan Karthik, Ryan Patrick, Elhadad Noémie
Department of Biomedical Informatics, Columbia University, New York, NY, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.
medRxiv. 2024 Dec 16:2024.12.13.24319010. doi: 10.1101/2024.12.13.24319010.
Do recent changes in European Society of Human Reproduction and Embryology (ESHRE) clinical guidelines result in more comprehensive diagnosis of women with endometriosis?
The latest shift in clinical guidelines results in diagnosis of more women with endometriosis but current ESHRE diagnostic criteria do not capture a sizable percentage of women with the disease.
Historically, laparoscopy was the gold standard for diagnosing endometriosis, a complex gynecological condition marked by a heterogeneous set of symptoms that vary widely among women. More recently, changes in clinical guidelines have shifted to incorporate imaging-based approaches such as transvaginal sonography and magnetic resonance imaging.
Retrospective, observational cohort study of women aged 15-49 years diagnosed with endometriosis in the United States (US) between January 1, 2013, and December 31, 2023.
PARTICIPANTS/MATERIALS SETTING METHODS: Data sources include US insurance claims data from the Merative MarketScan Commercial Database (CCAE), Merative MarketScan Multi-State Medicaid Database (MDCD), Optum de-identified Electronic Health Record dataset (Optum EHR), and electronic health record (EHR) data from a large academic medical center in New York City (CUIMC EHR). To examine the potential impact of expanding clinical criteria for the diagnosis of endometriosis, we validated and compared five cohort definitions based on different sets of diagnostic guidelines involving combinations of surgical confirmation, diagnostic imaging, guideline-recognized symptoms, and other symptoms commonly reported among women with endometriosis. We performed pairwise comparisons between cohorts and applied Bonferroni corrections to account for multiple comparisons.
We identified 491,048 women with a diagnosis of endometriosis across the CCAE, MDCD, Optum EHR, and CUIMC EHR datasets. Each cohort definition demonstrated strong positive predictive value (0.84-0.96), yet only 15-20% of cases were identified by all 5 cohort definitions. Women diagnosed with endometriosis based on imaging and symptoms were three years younger, on average, than women with a diagnosis based on surgical confirmation (mean age = 35 years [SD = 9] vs 38 years [SD = 8]; p<0.001). Women in cohorts based only on symptoms were two years younger than those based on surgery (36 years [SD = 8] vs 38 years [SD = 8]; p<0.001). More than one-fourth of cases presented with endometriosis-related symptoms but lacked surgical or imaging-related documentation required by ESHRE guideline criteria. Pain was reported among nearly all women with endometriosis. Abdominal pain and pain in the pelvis were the most prevalent (ranging from 69% to 90% of women in each cohort). Among approximately 2-5% of all endometriosis cases (14,795 total), women presented with pelvic and/or abdominal pain but none of the other symptoms noted in clinical guidelines.
Our study has potential biases associated with documentation practices and secondary data use of insurance claims and EHR data. Further, the phenotyping algorithms used rely on clinical codes that do not necessarily capture all ESHRE diagnostic criteria for endometriosis and may not be generalizable to women with atypical presentation of endometriosis.
High positive predictive value among all five cohort definitions despite poor overlap among cases identified illustrates both the heterogeneous presentation of the disease and importance of expanding diagnostic criteria. For example, cohorts derived from updated guidelines identified younger patients at time of diagnosis. Women diagnosed based on imaging had higher rates of emergency room visits while patients diagnosed via laparoscopy had a larger number of hospitalizations. The substantial number of cases with pelvic and/or abdominal pain but none of the other symptoms noted in clinical guidelines underscores the continued need for improved access to timely and appropriate care, particularly among those with non-classical symptoms, different care-seeking patterns, or lack of available surgical intervention.
欧洲人类生殖与胚胎学会(ESHRE)临床指南的近期变化是否能使子宫内膜异位症女性得到更全面的诊断?
临床指南的最新转变使更多子宫内膜异位症女性得到诊断,但当前ESHRE诊断标准未能涵盖相当比例的该病女性患者。
历史上,腹腔镜检查是诊断子宫内膜异位症的金标准,子宫内膜异位症是一种复杂的妇科疾病,症状多样,在女性中差异很大。最近,临床指南的变化转向纳入基于成像的方法,如经阴道超声和磁共振成像。
研究设计、规模、持续时间:对2013年1月1日至2023年12月31日期间在美国诊断为子宫内膜异位症的15至49岁女性进行回顾性观察队列研究。
参与者/材料、设置、方法:数据来源包括来自默克多市场扫描商业数据库(CCAE)、默克多市场扫描多州医疗补助数据库(MDCD)、Optum去识别电子健康记录数据集(Optum EHR)的美国保险理赔数据,以及纽约市一家大型学术医疗中心的电子健康记录(EHR)数据(CUIMC EHR)。为了研究扩大子宫内膜异位症诊断临床标准的潜在影响,我们基于不同的诊断指南集验证并比较了五个队列定义,这些指南集涉及手术确认、诊断成像、指南认可的症状以及子宫内膜异位症女性中常见的其他症状的组合。我们对队列进行了两两比较,并应用Bonferroni校正来处理多重比较。
我们在CCAE、MDCD、Optum EHR和CUIMC EHR数据集中识别出491,048例诊断为子宫内膜异位症的女性。每个队列定义都显示出很强的阳性预测值(0.84 - 0.96),但所有五个队列定义仅识别出15% - 20%的病例。基于成像和症状诊断为子宫内膜异位症的女性平均比基于手术确认诊断的女性年轻三岁(平均年龄 = 35岁[标准差 = 9]对38岁[标准差 = 8];p<0.001)。仅基于症状的队列中的女性比基于手术的女性年轻两岁(36岁[标准差 = 8]对38岁[标准差 = 8];p<0.001)。超过四分之一的病例出现了与子宫内膜异位症相关的症状,但缺乏ESHRE指南标准要求的手术或成像相关文件。几乎所有子宫内膜异位症女性都报告有疼痛。腹痛和盆腔疼痛最为普遍(每个队列中69% - 90%的女性有此类症状)。在所有子宫内膜异位症病例的约2% - 5%(共14,795例)中,女性出现盆腔和/或腹痛,但没有临床指南中提到的其他症状。
局限性、谨慎原因:我们的研究存在与记录实践以及保险理赔和EHR数据的二次使用相关的潜在偏差。此外,所使用的表型分析算法依赖于临床编码,这些编码不一定能涵盖子宫内膜异位症的所有ESHRE诊断标准,可能不适用于具有非典型子宫内膜异位症表现的女性。
尽管所识别的病例之间重叠性较差,但所有五个队列定义都具有较高的阳性预测值,这既说明了该疾病表现的异质性,也说明了扩大诊断标准的重要性。例如,源自更新指南的队列在诊断时识别出更年轻的患者。基于成像诊断的女性急诊就诊率较高,而通过腹腔镜检查诊断的患者住院次数较多。大量出现盆腔和/或腹痛但没有临床指南中提到的其他症状的病例强调了持续需要改善及时获得适当护理的机会,特别是在那些具有非经典症状、不同就医模式或缺乏可用手术干预的人群中。